These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8549405)

  • 1. Phase IV study (postmarketing surveillance) of Tarivid (ofloxacin) in China.
    Li JT; Yoshida M; Nakatsuka K
    Drugs; 1995; 49 Suppl 2():474-6. PubMed ID: 8549405
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-daily ofloxacin for hospitalised patients with severe bacterial infections.
    Landau Z; Arcavi L; Resnitzky P
    Drugs; 1995; 49 Suppl 2():472-3. PubMed ID: 8549404
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical efficacy of ofloxacin (tarivid) in patients with chronic bacterial prostatitis: preliminary results.
    Pust RA; Ackenheil-Koppe HR; Gilbert P; Weidner W
    J Chemother; 1989 Jul; 1(4 Suppl):869-71. PubMed ID: 16312678
    [No Abstract]   [Full Text] [Related]  

  • 4. Levofloxacin revisited.
    Med Lett Drugs Ther; 2011 Jul; 53(1368):55. PubMed ID: 21738109
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment in general practice. Effective, well tolerated therapy].
    MMW Fortschr Med; 2000 Sep; 142(37):58-9. PubMed ID: 11026226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-pharmacologic aspects of the use of ofloxacin].
    Kukes VG; Belitskaia RA; Dubova MN; Krasavina MIu; Posrednikova TA
    Antibiot Khimioter; 1996; 41(9):39-42. PubMed ID: 9005783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, multinational study with sequential therapy comparing ciprofloxacin twice daily and ofloxacin once daily.
    Bassaris H; Akalin E; Calangu S; Kitzes R; Kosmidis J; Milicevic M; Noack H; Raz R; Salewski E; Sukalo M
    Infection; 1995; 23(4):227-33. PubMed ID: 8522381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis.
    Halstensen A; Voltersvik P; Gossius G; Digranes A; Peterson LE; Rolstad T; Solberg CO
    Drugs; 1995; 49 Suppl 2():454-6. PubMed ID: 8549398
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacteriology of chronic suppurative otitis media: ofloxacin susceptibility.
    Yuen AP; Chau PY; Wei WI
    J Otolaryngol; 1995 Jun; 24(3):206-8. PubMed ID: 7674449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of ofloxacin in elderly patients.
    Bruch K; Blomer R
    Int J Clin Pharmacol Res; 1987; 7(3):195-8. PubMed ID: 3298084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fluoroquinolones after ciprofloxacin and ofloxacin.
    Hooper DC
    Curr Clin Top Infect Dis; 2000; 20():63-91. PubMed ID: 10943519
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of ofloxacin twice and three times daily in the treatment of respiratory tract infections.
    Sawae Y; Ninomiya K; Takaki K; Shimono N; Misumi H; Okada K
    Drugs; 1995; 49 Suppl 2():430-2. PubMed ID: 8549390
    [No Abstract]   [Full Text] [Related]  

  • 13. [A clinical evaluation of the efficacy of using Zanocin (ofloxacin) in surgery].
    Saenko VF; Viktorov AP; Golopykho LI; Nichitaĭlo ME; Gorshevikova EV
    Klin Khir; 1995; (9-10):18-9. PubMed ID: 8697205
    [No Abstract]   [Full Text] [Related]  

  • 14. Side effects of ofloxacin in clinical trials and in postmarketing surveillance.
    Jüngst G; Mohr R
    Drugs; 1987; 34 Suppl 1():144-9. PubMed ID: 3325257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of postmarketing experience with ofloxacin in Germany.
    Jüngst G; Mohr R
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():167-75. PubMed ID: 3053577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
    El'kun GB
    Vestn Otorinolaringol; 1999; (6):45-6. PubMed ID: 10596605
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute rhabdomyolysis during treatment with ofloxacin-a case report.
    Baril L; Maisonobe T; Jasson-Molinier M; Haroche J; Bricaire F; Caumes E
    Clin Infect Dis; 1999 Dec; 29(6):1598-9. PubMed ID: 10585836
    [No Abstract]   [Full Text] [Related]  

  • 18. Levofloxacin: penetration into sputum and once-daily treatment of respiratory tract infections.
    Nakamori Y; Miyashita Y; Nakatani I; Nakata K
    Drugs; 1995; 49 Suppl 2():418-9. PubMed ID: 8549384
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of 2 oral ofloxacin regimens for the treatment of bacteriuria in elderly subjects.
    Zorbas P; Giamarellou H; Staszewska-Pistoni M; Petrikkos G; Grammatikou M; Dontas AJ
    Drugs; 1995; 49 Suppl 2():384-6. PubMed ID: 8549370
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical trial of ofloxacin (Tarivid R)].
    Belovezhdov N; Angelova I; Talakova Ch
    Vutr Boles; 1988; 27(3):67-71. PubMed ID: 3061178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.